We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
(+6.9%)
Cap. Flow
+$366M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$48.8M |
| 2 |
Healthpeak Properties
DOC
|
+$16.2M |
| 3 |
Clorox
CLX
|
+$16.1M |
| 4 |
Brown-Forman Class B
BF.B
|
+$14.4M |
| 5 |
Hormel Foods
HRL
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$36.9M |
| 2 |
Apple
AAPL
|
+$10.8M |
| 3 |
JPMorgan Chase
JPM
|
+$6.74M |
| 4 |
Microsoft
MSFT
|
+$6.53M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$5.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.62% |
| 2 | Technology | 13.27% |
| 3 | Financials | 13.22% |
| 4 | Consumer Staples | 11.59% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEL
1501
DELISTED
Belmond Ltd.
BEL
| $121K | ﹤0.01% |
12,193
-1,659
| -12% | -$15.6K |
|
1502
Crocs
CROX
$6.81B
| $120K | ﹤0.01% |
10,660
-436
| -4% | -$4.23K |
|
1503
MBIA
MBI
$333M
| $119K | ﹤0.01% |
17,479
-76
| -0.4% | -$565 |
|
1504
MiMedx Group
MDXG
$640M
| $118K | ﹤0.01% |
14,738
-806
| -5% | -$6.27K |
|
|
LQ
1505
DELISTED
La Quinta Holdings Inc.
LQ
| $118K | ﹤0.01% |
10,377
-1,085
| -9% | -$12.9K |
|
|
BRKL
1506
DELISTED
Brookline Bancorp
BRKL
| $117K | ﹤0.01% |
10,612
-336
| -3% | -$3.76K |
|
|
TERP
1507
DELISTED
TerraForm Power, Inc
TERP
| $117K | ﹤0.01% |
+10,698
| New | +$98.9K |
|
|
ECYT
1508
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $116K | ﹤0.01% |
36,028
+585
| +2% | +$2.14K |
|
|
WIBC
1509
DELISTED
WILSHIRE BANCORP INC
WIBC
| $115K | ﹤0.01% |
11,015
-1,162
| -10% | -$12.5K |
|
|
TIVO
1510
DELISTED
TIVO INC
TIVO
| $114K | ﹤0.01% |
11,489
-395
| -3% | -$3.82K |
|
|
NIHD
1511
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $113K | ﹤0.01% |
35,618
+15,984
| +81% | +$67K |
|
|
APOL
1512
DELISTED
Apollo Education Group Inc Class A
APOL
| $111K | ﹤0.01% |
12,195
-698
| -5% | -$6.02K |
|
|
TVRD
1513
Tvardi Therapeutics
TVRD
$30M
| $110K | ﹤0.01% |
636
+13
| +2% | +$2.83K |
|
1514
Element Solutions
ESI
$9.11B
| $109K | ﹤0.01% |
12,297
+25
| +0.2% | +$233 |
|
|
ANTH
1515
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $109K | ﹤0.01% |
4,415
+146
| +3% | +$4.13K |
|
|
CIE
1516
DELISTED
Cobalt International Energy, Inc
CIE
| $108K | ﹤0.01% |
5,394
+2,953
| +121% | +$114K |
|
|
ADVM
1517
DELISTED
Adverum Biotechnologies
ADVM
| $106K | ﹤0.01% |
3,350
+1,217
| +57% | +$55K |
|
|
EGLT
1518
DELISTED
Egalet Corporation
EGLT
| $106K | ﹤0.01% |
21,386
+2,977
| +16% | +$17.6K |
|
|
FCH
1519
DELISTED
Felcor Lodging Trust
FCH
| $104K | ﹤0.01% |
16,680
-859
| -5% | -$6.02K |
|
1520
Ocular Therapeutix
OCUL
$1.96B
| $102K | ﹤0.01% |
20,623
+614
| +3% | +$6.08K |
|
1521
Eledon Pharmaceuticals
ELDN
$314M
| $100K | ﹤0.01% |
111
+1
| +0.9% | +$1.1K |
|
1522
Opko Health
OPK
$899M
| $100K | ﹤0.01% |
+10,655
| New | +$108K |
|
1523
Helix Energy Solutions
HLX
$1.41B
| $98K | ﹤0.01% |
14,557
-699
| -5% | -$5.06K |
|
|
CSR
1524
Centerspace
CSR
$938M
| $96K | ﹤0.01% |
1,482
-19
| -1% | -$1.24K |
|
1525
Arcturus Therapeutics
ARCT
$172M
| $92K | ﹤0.01% |
2,931
+59
| +2% | +$1.86K |
|
Similar funds
ProShare Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.
- ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
- ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
- ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
- ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
- ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
- ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.
Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.